Introduction {#s1}
============

Autophagy is a cellular process that maintains homeostasis via clearance of cellular components, degradation of damaged organelles and protection against viral and bacterial invasion ([@bib3]). Autophagy entails the de novo formation of a double membrane structure (termed the isolation membrane), maturation into a sealed autophagosome, and delivery of substrates to the lysosome for degradation ([@bib19]; [@bib21]). Macroautophagy and selective autophagy are two distinct modes of autophagy that differ in their initiation mechanisms and cargo specificity ([@bib39]; [@bib41]). During cellular starvation conditions, macroautophagy functions by the initial formation of an isolation membrane at ER exit sites and expands ([@bib8]; [@bib28]), engulfing cytoplasmic debris in a nonspecific manner. Selective autophagy functions via a set of autophagy adaptor proteins, which bind cargos directly or via polyubiquitin chains ([@bib41]). The isolation membrane forms on the labeled cargo and tightly engulfs the cargo during maturation. A complex cascade of autophagy (ATG) related proteins, including the ULK1 complex, Class III PI3K complex, WIPIs, ATG12-5-16, LC3, ATG9, cargo adaptors, and others are required for mammalian autophagy ([@bib2]; [@bib11]). Through numerous studies, selective autophagy pathways for mitochondria (mitophagy), aggregates (aggrephagy), lysosomes (lysophagy), endoplasmic reticulum (ER-phagy), bacteria (xenophagy) and other cargos have been discovered ([@bib41]). Correspondingly, a set of adaptors have been identified which function to decorate cargos for degradation. Nuclear domain 10 protein 52 (NDP52), optineurin, CCPG1, TAX1BP1 and p62 represent a subset of such adaptors ([@bib15]).

NDP52, also known as Calcium Binding And Coiled-Coil Domain 2 (CALCOCO2), is a multifunctional autophagy adaptor that is crucial for both xenophagy and mitophagy ([@bib16]; [@bib37]). Knock out studies of NDP52 show a severe impairment of autophagic protection against *Salmonella* invasion ([@bib36]) and diminished recruitment of the ULK1 complex during mitophagy ([@bib16]). The N-terminal SKICH domain of NDP52 forms a network of interactions in xenophagy and mitophagy pathways ([@bib25]; [@bib32]). Recent work has shown the direct interaction of NDP52 with FIP200, a protein in the autophagy initiation ULK1 complex ([@bib25]; [@bib35]). This interaction is crucial for recruitment of ULK1 to initial phagophore sites, ultimately leading to the engulfment and degradation of selected cargo. NDP52 contains a LIR motif which is required for its interaction with LC3, a hallmark of the autophagosome membrane. Lastly, NDP52 has two domains that recognize cargo; a GALB1 domain, which interacts with galectin-8, and a UBZ domain that recognizes polyubiquitin conjugated to the bacterial surface ([@bib30]).

The ULK1 complex is comprised of the ULK1 kinase, focal adhesion kinase family interacting protein of 200 kDa (FIP200), autophagy-related protein 13 (ATG13), and ATG101 ([@bib7]; [@bib9]; [@bib13]; [@bib18]; [@bib20]). ULK1 and 2 are interchangeable threonine/serine kinases which function as the catalytic subunit of the ULK1 complex. The N-terminal kinase domain is followed by a \~ 550 residue intrinsically disordered region (IDR) and a C-terminal early autophagy tethering (EAT) domain which recruits ULK1 to the rest of the complex via ATG13 ([@bib1]). This network of interactions is conserved in the yeast homolog Atg1 complex ([@bib6]; [@bib27]). FIP200 is a 1594 residue protein which contains a dimeric N-terminal scaffolding domain ([@bib26]), an IDR, a coiled-coil (CC) region and a C-terminal 'Claw' domain ([@bib33]). The C-shaped N-terminal domain dimer of FIP200 scaffolds assembly of the ULK1 complex while the C-terminal Claw domain interacts with cargo adaptors, including NDP52, p62 and CCPG1 ([@bib25]; [@bib33]; [@bib35]). ATG13/101 form a HORMA dimer which interacts with PI3K and is required for ULK1 complex function and assembly ([@bib24]; [@bib29]). Little is known about the structure and function of the massive CC domain of FIP200, beyond the crystal structure of its very C-terminal 100 residues ([@bib33]) and the identification of an NDP52 binding site between residues 1351--1441 ([@bib25]).

The ULK1 complex is rapidly recruited to invading bacteria and damaged mitochondria following their ubiquitination via its interaction with NDP52 ([@bib25]; [@bib34]; [@bib35]). As the most upstream of the autophagy core complexes, ULK1 complex recruitment is pivotal to subsequent events in autophagosome biogenesis. The nature of the structural changes in the ULK1 complex following NDP52 engagement and how those changes influence recruitment of membranes and downstream autophagy components is, however, almost entirely unknown.

Despite progress in crystallizing substructures of the ULK1 complex ([@bib18]) and an intermediate resolution cryo-EM structure of the FIP200 NTD ([@bib26]), progress on the intact ULK1 complex containing full-length FIP200 has been very challenging. FIP200 is 1594 amino acid residues in length, and apart from the NTD and C-terminal Claw, consists of an intrinsically disordered region (IDR) and a massive 710-residue CC. These features have made full-length FIP200 and the intact ULK1 complex exceptionally difficult for biochemical and structural studies. Here we demonstrate that purified full length FIP200 forms an extended and dynamic structure, which scaffolds the ULK1 complex at its dimeric C-shaped N-terminal domain. Binding of NDP52 to full length FIP200 and the ULK1 complex does not change the conformation of the N-terminal domain, but alters that of a large portion of the FIP200 CC domain. This interaction increases the membrane affinity of FIP200. NDP52 induces robust recruitment of the ULK1 complex to giant unilamellar vesicles (GUVs) by exposing a membrane binding site within the CC domain of FIP200.

Results {#s2}
=======

Full length FIP200 forms an elongated scaffold for ULK1 and adaptor binding {#s2-1}
---------------------------------------------------------------------------

We sought to investigate the structure of purified full-length FIP200. To express and purify full-length FIP200, a dual tag construct was developed. Wild-type FIP200 was expressed with a glutathione S-transferase (GST) tag fused to the N-terminus and a maltose binding protein (MBP) tag on the C terminus. After affinity purification, full-length GST-FIP200-MBP was characterized using negative stain electron microscopy (NSEM) ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Full length FIP200 single particles showed an extended density with a C-shaped density at one end, corresponding to the dimeric FIP200NTD previously resolved ([@bib26]). Density for the GST tags can be seen in the center of the FIP200 NTD dimer ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). This N-terminal density is followed by a long meandering density which we assigned as the CC domain (residues 790--1500). The IDR region (640-790) was not visualized. The CC domain of FIP200 has segments of predicted dimeric coiled-coils and linker regions. Features visualized at the C-terminus of FIP200 correspond to density for two MBP tags (40 kDa each) and the Claw dimer (22 kDa) ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}).

![EM and HDX-MS of full-length FIP200.\
(**A**) Negative stain EM single particles of full length FIP200 alone. Scale bar 50 nm. (**B**) Histogram of FIP200 path length and end-to-end distances. (**C**) Difference of Hydrogen Deuterium Exchange percentages of the FIP200 alone vs FIP200:ATG13:ATG101:ULK1 at 60 s time point. All values are mean (Blue) ± SD (Grey). N = 3 replicates.](elife-59099-fig1){#fig1}

The CC was observed in a variety of conformations with varying lengths and curvatures. FIP200-CC domain comprises 710 residues which, if uninterrupted, would span about 105 nm. The contour lengths of the CC region in particles analyzed by NSEM ranged from 37 nm to 107 nm, with a mean length of 79 nm ([Figure 1B](#fig1){ref-type="fig"}). The presence of some particles with contour lengths far below the predicted maximum suggests that the CC is capable of folding back onto itself. The variability of the total length corresponds to a range of end-to-end distances distributed from 32 nm to 94 nm with a mean of 69 nm ([Figure 1B](#fig1){ref-type="fig"}). It is clear that the FIP200 N-terminus is separated from the C-terminus Claw domain. This spatially separates the site of ULK1 assembly at the NTD and the binding site of the cargo adaptors NDP52 near the C-terminal end of the CC ([@bib25]; [@bib35]) and p62 at the Claw domain C-terminal to the CC ([@bib33]).

To investigate how the ULK1 complex assembles on full-length FIP200, we employed hydrogen-deuterium exchange mass spectrometry analysis (HDX-MS) on FIP200 alone and the full-length ULK1 complex. Purified ULK1 complex was active with respect to the synthetic substrate, ULKtide ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Difference maps for H/D exchange showed a clear protection pattern in the FIP200NTD, similar to our previous results on the FIP200 NTD alone ([@bib26]). Specifically, peptides spanning residues 75--80, 157--165, 313--324, 350--356, 435--469 and 532--541 showed increases in protection of \>10% after exchanging for 60 s ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). No large changes (\>10%) were observed in FIP200 CC or Claw. This implies that assembly of the ULK1 complex with full length FIP200 does not affect the dynamics of the cargo-recognizing CC and Claw. Thus, FIP200 is a modular protein whose NTD engages with the rest of the ULK1 complex and whose CC and Claw engage independently with cargo adaptors.

ULK1 complex engages NDP52 only via FIP200 {#s2-2}
------------------------------------------

Next, we used HDX-MS to systematically analyze how the H/D exchange rate of the ULK1 complex changed in the presence of NDP52. To validate the ULK1 complex sample, the complex was expressed with fluorescent GFP tags on ATG13 and ATG101 and purified. Labeled ULK1 complex was mixed with GST-NDP52, GST-4xUb and glutathione beads. The fluorescence signal was quantified for each reaction condition ([Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}). The ULK1 complex was specifically pulled down by GST-NDP52, but not by GST-4xUb or GSH beads alone. This confirmed that the ULK1 complex recognizes cargo adaptors but not poly-ubiquitin chains directly in our in vitro system.

In the presence of NDP52, no large changes (\<-10% or \>10%) were identified in peptides from ATG13, ATG101, ULK1 or the FIP200NTD ([Figure 2A--D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, all proteins at 2 μM, except FIP200 at 4 μM and NDP52 at 16 μM). A lack of HDX difference suggests that NDP52 does not directly or allosterically modulate these regions upon binding to the FIP200 CTD. However, our analysis showed three regions of the CC domain of FIP200 with significant protection in the presence of NDP52. Peptides of residues 1290--1320, 1339--1392 and 1462--1470 showed a decrease of deuterium exchange of \>10% ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). Residues in the 1339--1392 region (L1371, L1378, L1385, and L1392) corresponds to the previously proposed as a binding site of NDP52 ([@bib25]; [@bib35]). Residues 1290--1320 and 1339--1392 display a higher level of protection than 1462--1470. Unexpectedly, an extensive region of the CC N-terminal to the NDP52 binding site, spanning FIP200 residues 800--1250, especially 935--1073, had increased H/D exchange rate after NDP52 binding ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}- Table S1). These changes suggest that the N-terminal part of the CC is destabilized upon NDP52 binding.

![HDX-MS mapping of NDP52 interactions with the ULK1 complex.\
(**A--D**) Difference of Hydrogen Deuterium Exchange percentages of the ATG13 (**A**), ATG101 (**B**), ULK1 (**C**) and FIP200 (**D**) in ULK1 complex vs in ULK1 complex with NDP52 at the 60 s time point. All values are mean (Blue) ± SD (Grey). N = 3 replicates. (**E**) Pull-down efficiency of GFP-tagged wild type ULK1 complex or GFP-FIP200 by glutathione sepharose beads coated with different concentrations of GST-NDP52 as baits. All values are mean ± SD. N = 4 biological replicates. (**F**) Pull-down assays of mutant FIP200 constructs (M1--M8) and wild type with NDP52. Both GSH and Amylose resin were used to pull down GST-FIP200(1274 C):MBP-NDP52 complex from lysate of overexpressing HEK cells. The pull-down results were visualized by SDS-PAGE and Coomassie blue staining.\
Figure 2---source data 1.Source data for graph in [Figure 2E](#fig2){ref-type="fig"}.](elife-59099-fig2){#fig2}

To confirm the conclusion from HDX-MS that ULK1, ATG13 and ATG101 are not involved in NDP52 binding, fluorescent FIP200 alone and the complete ULK1 complex were compared in a GST pulldown assay with GST-NDP52 as bait ([Figure 2E](#fig2){ref-type="fig"}). FIP200 alone and the full ULK1 complex bound to the same extent to 0.1, 0.3 and 1 uM of GST-NDP52. To further investigate which regions of FIP200 bind directly to NDP52, we mutated eight regions identified by our HDX-MS analysis ([Figure 2D](#fig2){ref-type="fig"}). Regions selected for mutation were replaced by a poly Gly-Ser sequence of equal length to the wild-type region. GST pulldown assays showed that the expression of FIP200 was unaffected by the Gly-Ser mutations ([Figure 2F](#fig2){ref-type="fig"}, right). In addition, both GST and MBP pulldown assays confirmed that mutation of region 4 (1355--1362), 5 (1363--1370) and 6 (1371--1378) in FIP200 impaired the interaction with NDP52, while the rest showed small decreases in binding affinity (region 3 and 7) or minimal (region 1, 2 and 8) effects ([Figure 2F](#fig2){ref-type="fig"}).

FIP200 CC interacts with membranes {#s2-3}
----------------------------------

The finding that NDP52 increased the H/D exchange rate of a subset of the coiled-coil (800--1250) region of FIP200 stimulated our curiosity about the physiological function of this CC region. We thus used HDX-MS to systematically analyze if the ULK1 complex interacts with SUVs containing PI lipids. No large changes (\<-10% or \>10%) were identified in peptides from ATG13 or ATG101 which suggests that PI containing membranes do not directly or allosterically modulate these proteins of the ULK1 complex ([Figure 3A,B](#fig3){ref-type="fig"}). In our assay, two regions of FIP200 showed significant protection. Residues within the N-terminal domain (539-564) showed moderate protection \~10%. However, the strongest protection profile (5--45%) was seen across an extended portion of the CC domain, covering residues 844--1073 ([Figure 3C](#fig3){ref-type="fig"}, [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}).

![HDX-MS mapping of membrane interactions with the ULK1 complex.\
(**A--C**) Difference of Hydrogen Deuterium Exchange percentages of the ATG13 (**A**), ATG101 (**B**) and FIP200 (**C**) in ULK1 complex vs in ULK1 complex with POPS/POPI SUV at the 60 s time point. All values are mean (Blue) ± SD (Grey). N = 3 replicates. (**D**) Liposome sedimentation assay of FIP200 truncations alone with POPS/POPI and POPC/POPE SUVs. Results were visualized by SDS-PAGE and Coomassie blue staining with the supernatant fractions (S) and pellet fractions (P).](elife-59099-fig3){#fig3}

To refine the mapping of the membrane binding site within FIP200, we compared truncations of the FIP200 in a liposome sedimentation assay. NTD (N-640) and CTD (636-C) FIP200 proteins were mixed with SUVs before separation into pellet and supernatant fractions ([Figure 3D](#fig3){ref-type="fig"}). The FIP200 CTD (636-C) containing the CC domain, but not FIP200 NTD, co-precipitated with membranes. This was most prominent in SUVs containing an acidic lipid mixture of PS/PI. Furthermore, a smaller amount of the FIP200 CTD was observed in the pellet of SUVs containing PC/PE. The interaction between the CC domain of FIP200 and membranes raises the possibility that NDP52 binding at the C-terminal CC domain could trigger destabilization or opening of the N-terminal CC domain, increasing exposure of hydrophobic residues and so stimulating membrane binding to the ULK1 complex.

Reconstitution of NDP52-stimulated membrane binding of the ULK1 complex {#s2-4}
-----------------------------------------------------------------------

To investigate how NDP52 binding effects membrane recruitment of the ULK1 complex, we reconstituted this event on GUVs with an ER-like lipid composition. FIP200 alone was only minimally recruited to GUVs ([Figure 4A,B](#fig4){ref-type="fig"}). Additionally, minimal GUV binding was observed in the presence of His-tagged NDP52. GST-tagged NDP52 showed a small increase in membrane binding ([Figure 4A,B](#fig4){ref-type="fig"}). Given that the GST tag forms a native dimer, this suggested the oligomeric state of NDP52 was crucial for the activation of FIP200 membrane binding.

![Reconstitution of NDP52-stimulated membrane binding of the ULK1 complex.\
The schematic drawing illustrates the reaction setting. Colors indicate fluorescent protein fused components. Components in gray are not labeled but are present in the reaction mix. (**A**) Representative confocal micrographs showing the membrane recruitment of GFP-FIP200. GFP-FIP200 mixed with His-NDP52 or GST-NDP52 was incubated with GUVs, either in the absence or presence of GST-4xUb at room temperature. GFP-FIP200 alone or mixed with GST-4xUb was also incubated with GUVs at room temperature as controls. Images taken at indicated time points were shown. Scale bars, 10 µm. (**B**) Quantitation of the kinetics of FIP200 recruitment to the membrane from individual GUV tracing in A (means ± SDs; N = 51 (-); 51 (His-NDP52); 48 (GST-NDP52); 53 (GST-4xUb); 72 (GST-4xUb+ His-NDP52); 57 (GST-4xUb+ GST-NDP52)). (**C**) Representative confocal micrographs showing the membrane recruitment of GFP-ULK1 complex. GFP-ULK1 complex alone or mixed with His-NDP52 or GST-NDP52 in the presence of GST-4xUb was incubated with GUVs at room temperature. Images taken at indicated time points were shown. Scale bars, 10 µm. (**D**) Quantitation of the kinetics of ULK1 complex recruitment to the membrane from individual GUV tracing in C (means ± SDs; N = 54 (-); 47 (GST-4xUb+ His-NDP52); 49 (GST-4xUb+ GST-NDP52)).\
Figure 4---source data 1.Source data for GUV image quantitation data in [Figure 4](#fig4){ref-type="fig"}.](elife-59099-fig4){#fig4}

To test how NDP52 oligomeric state effects FIP200 recruitment we included GST-tagged linear tetra-ubiquitin, which mimics poly-ubiquitinated protein substrates and induces the oligomerization of NDP52 in vitro. No recruitment of FIP200 was detected to GUVs in the presence of GST-4xUb alone, consistent with the lack of a direct interaction between FIP200 and Ub ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). In the presence of GST-4xUb and NDP52, FIP200 rapidly coalesced into clusters and was robustly recruited to the GUV surface ([Figure 4A,B](#fig4){ref-type="fig"}). These clusters began to form within 5 min of mixing ([Figure 4A,B](#fig4){ref-type="fig"}). After 35 min, FIP200 was clustered into large, continuous domains on the GUVs ([Figure 4A,B](#fig4){ref-type="fig"}).

We then tested the membrane recruitment of the entire ULK1 complex under equivalent conditions. Similarly to FIP200 alone, full-length ULK1 complex formed clusters with NDP52 and poly-ubiquitin but not in their absence ([Figure 4C,D](#fig4){ref-type="fig"}). Recruitment of the ULK1 complex was stronger with the dimeric GST-NDP52 than the monomeric His-NDP52. Together, these data show that oligomerized NDP52 activates membrane recruitment of the ULK1 complex. Furthermore, the higher order assembly of NDP52 via poly-ubiquitin stimulates membrane binding.

NDP52 binding is required for the membrane recruitment of ULK1 {#s2-5}
--------------------------------------------------------------

To validate that the middle region of FIP200 (residues 790--1050) was the membrane binding site of ULK1 complex as suggested by HDX-MS, we generated FIP200 constructs with the middle region (residues 790--1050) deleted (FIP200^ΔMR^). The NDP52 binding region from HDX-MS, residues 1363--1370 was also converted to poly Gly-Ser (FIP200^ΔNDP52^) in a separate mutation. Neither mutation altered the stability of FIP200 on the basis that both mutants yielded protein at the same level as wild type ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). A microscopy-based bead assay was used to confirm that FIP200^ΔMR^ still bound to NDP52 ([Figure 5A,B](#fig5){ref-type="fig"}). WT and FIP200^ΔMR^ ULK1 complex were both robustly recruited to GST-NDP52 beads ([Figure 5A,B](#fig5){ref-type="fig"}). FIP200^ΔNDP52^ ULK1 was not recruited to the GST-NDP52 beads ([Figure 5A,B](#fig5){ref-type="fig"}), which is consistent with our previous pulldown data ([Figure 2F](#fig2){ref-type="fig"}).

![NDP52 allosterically activates membrane association of the ULK1 complex.\
(**A**) Microscopy-based bead protein interaction assay with glutathione sepharose beads coated with GST-NDP52 as baits and incubated with GFP-tagged wild type ULK1 complex or mutant as prey. Representative confocal micrographs are shown. Scale bars, 50 µm. (**B**) Quantification of the GFP-ULK1 complex signal intensity measured on glutathione sepharose beads coated with GST-NDP52 (means ± SDs; N = 20). (**C**) Representative confocal micrographs showing the membrane recruitment of GFP-ULK1 complex. GFP-tagged wild type ULK1 complex or mutant was mixed with GUVs in the presence of GST-NDP52 and GST-4xUb at room temperature. Images taken at indicated time points were shown. Scale bars, 10 µm. (**D**) Quantitation of the kinetics of ULK1 complex recruitment to the membrane from individual GUV tracing in A (means ± SDs; N = 22 (WT); 25 (ΔMR); 22 (ΔNDP52)).\
Figure 5---source data 1.Source data for GUV image quantitation data in [Figure 5](#fig5){ref-type="fig"}.](elife-59099-fig5){#fig5}

We proceeded to test the membrane recruitment of ULK1 complexes containing these two mutants. WT ULK1 complex was recruited strongly in the presence of GST-NDP52 and GST-4xUb ([Figure 5C,D](#fig5){ref-type="fig"}). FIP200^ΔMR^ ULK1 complex bound more weakly to GUVs ([Figure 5C,D](#fig5){ref-type="fig"}), whereas FIP200^ΔNDP52^ ULK1 complex completely abolished membrane recruitment ([Figure 5C,D](#fig5){ref-type="fig"}). These data show that the NDP52-FIP200 interaction is essential for membrane recruitment. The CC membrane binding site is also important for binding, but residual binding still occurs in when the CC membrane binding site is removed. We tested whether NDP52 itself could bind membranes. NDP52 was recruited to the GUV membranes either when it was tagged with GST or upon the addition of poly-ubiquitin ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). From this finding, we concluded that the residual binding to GUVs is due to membrane binding by NDP52, not to additional membrane binding sites on the ULK1 complex.

Discussion {#s3}
==========

The year 2019 saw a paradigm shift in the initiation of selective autophagy ([@bib19]). Recognition of p62 ([@bib33]) and NDP52 ([@bib25]; [@bib35]) by FIP200 was shown to the key triggering event responsible for recruiting the ULK1 complex to cargo. The binding sites of p62 and NDP52 were mapped to the Claw ([@bib33]) and CC C-terminus ([@bib25]) respectively, and the structure of the Claw and a small part of the CC were determined ([@bib33]). All of the many downstream events remained unclear, however, as did the structure of the great majority of FIP200. Here we obtained the first structural view of full-length FIP200 and the intact ULK1 complex. In the context of the structure, we formulated a model for the allosteric activation by NDP52 of the next step following ULK1 complex recruitment to cargo, namely membrane recruitment.

In a related study, we recently showed that the N-terminal domain (NTD) of FIP200, consisting of the first 640 amino acids, comprised a C-shaped dimeric hub for assembly of the rest of the ULK1 complex. A single molecule of ATG13 was shown to bind to the NTD dimer. ATG13 in turn contacts ATG101 and ULK1 itself. The ULK1 complex is unusually loosely organized, lacking extensive direct contacts between FIP200, ULK1, and ATG101. Biochemical and structural studies of the 1594-residue FIP200 have been exceptionally challenging, and it has only now been possible to visualize the intact molecule. The C-termini of the two FIP200 NTDs in the C-shaped dimer is located near the center. We have now confirmed that the CC projects away from the center of the NTD. Thus, the symmetry of the NTD matches the symmetry of the FIP200 CC, which is parallel and a dimer ([@bib33]). FIP200 CC has a modal end-to-end distance of \~75 nm and is partially flexible, making it ideally suited to its function of connecting cargo to other components of the ULK1 complex and to membranes over substantial distances, much as seen with other coiled-coil based tethers such as the endosomal tether EEA1 ([@bib22]) and the Golgi tether GCC185 ([@bib4]).

The data presented here suggest that the membrane binding region (MR) in the N-terminal portion of FIP200 CC is the principal, although not sole, membrane binding site responsible for the first ULK1 complex membrane recruitment event in autophagy. NDP52 and, most probably, the FIP200 NTD also contribute to membrane interactions. [Figure 6](#fig6){ref-type="fig"} depicts the series of events that these data lead us to believe underlie membrane recruitment downstream of NDP52-ubiquitin engagement. In solution, FIP200 exists as isolated dimers with the MR region in a helical conformation that sequesters the hydrophobic residues. When ubiquitin is conjugated to and presented on the surface of damaged mitochondria, invading bacteria, or other substrates, NDP52 is recruited to these sites by directly binding to the clustered ubiquitin on their surfaces ([@bib30]; [@bib31]; [@bib38]). FIP200 is then recruited to clustered NDP52 via its NDP52 binding site in the C-terminal part of its CC. We found that engagement to NDP52 destabilizes the conformation of the N-terminal part of the FIP200 CC and increases membrane affinity, presumably by melting the coiled coil and increasing the exposure of hydrophobic side chains in this region. These changes occur simultaneously with clustering of multiple FIP200 dimers. In our study, the role of clustering in driving membrane affinity was evidenced by the increase in binding when GST-fusions were used, because GST is dimeric. Taken together, the MR conformational change and higher-order clustering drives strong membrane recruitment.

![Model for ULK1 complex membrane recruitment.\
Before engagement with NDP52, the FIP200 middle region (790--1050) forms a stable coiled-coil in a low membrane affinity state and the CTD and 'Claw' domains are unbound. Initially, NDP52 is recruited by interaction with ubiquitin to autophagic cargo in both xenophagy and mitophagy. FIP200 CTD binds directly to NDP52, driving clustering of FIP200 along with an allosteric conformational change in the MR region. These clusters form a hub for ULK1 auto-transphosphorylation and a site for initial recruitment of phagophore membranes.](elife-59099-fig6){#fig6}

FIP200 is thought to initially localize to phosphatidylinositol synthase (PIS)-enriched ER subdomains prior to PI(3)P generation by the autophagic PI 3-kinase complex I ([@bib23]). In the presence of an ER-like synthetic lipid mixture, only the MR showed significant changes in HDX. A basic patch on the ATG13 HORMA domain structure ([@bib24]; [@bib29]) was been reported to interact with PI(3)P ([@bib14]) and so sustain ULK1 complex localization at the omegasome subsequent to PI 3-kinase activation. Our synthetic lipid mixture intentionally omitted PI(3)P to reflect the earliest step in activation. The conserved EAT domain of the yeast ULK1 ortholog Atg1 binds to highly curved ER-like vesicles, but only in the absence of Atg13, and its lipid-binding role is probably important only in later steps of autophagosome biogenesis ([@bib17]). The MR is not electropositive in character, unlike most membrane binding domains ([@bib10]), but this is in keeping with the neutral character of ER lipids. Our data suggest a model wherein NDP52 binding to the C-terminus of FIP200 CC promotes lipid binding at the MR, so allowing a tether to be formed between cargo and the ER subdomain destined to become the omegasome. These data are consistent with the critical role of the NDP52-binding residues of FIP200 as demonstrated in both mitophagy ([@bib35]) and xenophagy ([@bib25]).

In this study, we focused on NDP52 rather than p62 because NDP52 binds much more tightly to FIP200, which facilitated the HDX-MS and biochemical experiments. It remains to be seen if the principles of membrane recruitment revealed here are general to p62 and other adaptors. The stimulation of the effect seen by using dimeric GST fusions of 4xUb and NDP52 show that multimerization is important for promoting membrane binding. While the binding site of NDP52 on FIP200 CC appears to be unique, clustering of cargo adaptors on ubiquitinated cargo is a general aspect of selective autophagy ([@bib15]; [@bib41]). The role of the membrane-recruitment mechanism described here in bulk autophagy also remains to be determined, but to the extent that cargo-like ubiquitin condensates ([@bib40]) mediate bulk autophagy, similar principles seem likely to apply.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                Designation                                                      Source or\                              Identifiers                                                                                               Additional\
  (species) or\                                                                                 reference                                                                                                                                         information
  resource                                                                                                                                                                                                                                        
  ---------------------------- ---------------------------------------------------------------- --------------------------------------- --------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------
  Cell line (*Homo sapiens*)   HEK GnTi                                                         ATCC                                    CRL-3022                                                                                                  

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200-MBP                                        This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-Atg13                                                       This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-ATG101                                            This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-\                                                           This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.
                               MBP-TSF-TEVcs-ULK1                                                                                                                                                                                                 

  Recombinant DNA reagent      pCAG-\                                                           This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.
                               EGFP-ATG13                                                                                                                                                                                                         

  Recombinant DNA reagent      pCAG-\                                                           This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.
                               GST-TEVcs-EGFP-ATG101                                                                                                                                                                                              

  Recombinant DNA reagent      pCAG-\                                                           This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.
                               GST-TEVcs-EGFP-FIP200-MBP                                                                                                                                                                                          

  Recombinant DNA reagent      pGST2-NDP52                                                      This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-MBP-NDP52                                                   This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pGEX5-4xUb                                                       [@bib40]                                                                                                                                          From Sascha Martens group (Vienna)

  Recombinant DNA reagent      pGST2-NDP52-mCherry                                              This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-TSF-NDP52-mCherry                                           This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pET-6xHis-TEVcs-NDP52                                            This paper                                                                                                                                        From Sascha Martens group (Vienna)

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(1274 C)                                    This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(N-640)-MBP                                 This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(636-C)-MBP                                 This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(delta790-1050, ΔMR)-MBP                    This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(1363-1370Mut, ΔNDP52)-MBP                  This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Recombinant DNA reagent      pCAG-GST-TEVcs-FIP200(1274 C) M1-M8                              This paper                                                                                                                                        See 'plasmid construction' section. Can be obtained from the Hurley lab.

  Commercial assay or kit      ADP-Glo Max Assay                                                Promega, Madison, WI                    V6930                                                                                                     

  Software, algorithm          Proteome Discoverer 2.1                                          Thermo Fisher Scientific, Waltham, MA   <https://www.thermofisher.com/order/catalog/product/OPTON-30795>                                          

  Software, algorithm          HDExaminer                                                       Sierra Analytics, Modesto, CA           <http://massspec.com/hdexaminer/>                                                                         

  Software, algorithm          Nikon Elements microscope imaging software 4.60                  Nikon Corporation, Tokyo, Japan         <https://www.nikoninstruments.com/Products/Software/NIS-Elements-Advanced-Research/NIS-Elements-Viewer>   

  Software, algorithm          Custom Python scripts and Jupyter notebooks                      This paper                                                                                                                                        Access at <https://github.com/Hurley-Lab/FIP-NDP52-paper>

  Software, algorithm          Relion                                                                                                   SCR_016274                                                                                                

  Other                        Glutathione Sepharose 4B GST-tagged protein purification resin   GE healthcare, Chicago, IL              Cat\#17075605                                                                                             

  Other                        Amylose Resin                                                    New England Biolabs, Ipswich, MA        Cat\#E8021L                                                                                               

  Other                        Strep-Tactin Superflow high capacity 50% suspension              IBA Lifesciences,\                      Cat\# 2-1208-010                                                                                          
                                                                                                Göttingen,\                                                                                                                                       
                                                                                                Germany                                                                                                                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmid construction {#s4-1}
--------------------

The sequences of all DNAs encoding components of ULK1 complex were codon optimized, synthesized and then subcloned into the pCAG vector. All DNAs encoding NDP52 (except His-NDP52) were subcloned into pCAG or pGST2 vectors. The linear tetraubiqutin expressed in pGEX5 and His-NDP52 in pET were obtained from Sascha Martens (Vienna). Proteins were tagged with GST, MBP or TwinStrep-Flag (TSF) for affinity purification or pull-down assays. N-terminal GST, MBP or TSF tags were followed by a tobacco etch virus cleavage site (TEVcs). All constructs were verified by DNA sequencing. Details are shown in the key resources table.

Protein expression and purification {#s4-2}
-----------------------------------

GST-FIP200-MBP, FIP200(N-640)-MBP, FIP200(636-C)-MBP and full-length ULK1 complex protein samples used for NSEM, HDX-MS, fluorescent pulldown assays, ADP-Glo kinase assays and liposome sedimentation assays were expressed in HEK293-GnTI suspension cells by using the polyethylenimine (Polysciences) transfection system. Cells were transfected at a concentration of 2--3 × 10^6^/mL and harvested after 48 hr. The harvested cells were pelleted at 500 x g for 10 min at 4°C, washed with PBS once, and then stored at −80°C. The pellets were then lysed with lysis buffer containing 50 mM Tris-HCl pH 7.4, 200 mM NaCl, 2 mM MgCl~2~, 1 mM TCEP, 1% Triton X-100, 10% Glycerol and protease inhibitors (Roche) before being cleared at 16000 x g for 30 min at 4°C. The supernatant was then incubated with Glutathione Sepharose 4B (GE Healthcare) or Strep-Tactin Sepharose (IBA Lifesciences) as appropriate, with gentle shaking for 12 hr at 4°C. The mixture was then loaded onto a gravity flow column, and the resin was washed extensively with wash buffer (50 mM HEPES pH 8.0, 200 mM NaCl, 1 mM MgCl~2~ and 1 mM TCEP). The proteins were eluted with wash buffer containing 50 mM glutathione or 10 mM desthiobiotin, as appropriate. To purify GST-FIP200-MBP, FIP200(N-640)-MBP, FIP200(636-C)-MBP, FIP200-MBP and EGFP-FIP200-MBP, eluted protein samples may be treated with TEV protease at 4°C overnight before flowing through Amylose resin (New England Biolabs) for a second step of affinity purification. To purify ULK1 complex and EGFP-ULK1 complex, FIP200/ATG13/ATG101 subcomplex and ULK1 were expressed and purified separately. After the first step of affinity purification, the two samples were mixed, cleaved by TEV at 4°C overnight, and subjected to a second step of affinity purification using the MBP tag. The eluted sample was passed through a Strep-Tactin Sepharose (IBA Lifesciences) column to clear the MBP-TSF tag from ULK1. The final buffer after MBP affinity purification is 20 mM HEPES (pH 8.0), 200 mM NaCl, 1 mM TCEP and 50 mM Maltose.

GST-NDP52, GST-NDP52-mCherry, 6xHis-NDP52 and GST-4xUb protein samples were expressed in *E. coli* (BL21DE3) at 18°C overnight. The harvested cells were pelleted at 4500 x g for 20 min at 4°C, washed with PBS once, and then stocked in −80°C if needed. The pellets were then suspended in a buffer containing 50 mM Tris-HCl pH 7.4, 200 mM NaCl, 2 mM MgCl~2~, 1 mM TCEP and protease inhibitors (Roche), and sonicated before being cleared at 16000 x g for 30 min at 4°C. The supernatant was incubated with Glutathione Sepharose 4B (GE Healthcare) or Ni-NTA Resins (Qiagen) as appropriate, with gentle shaking for 2 hr at 4°C. The mixture was then loaded onto a gravity flow column, and the resin was washed extensively with wash buffer (50 mM HEPES pH 8.0, 200 mM NaCl, 1 mM MgCl~2~ and 1 mM TCEP). The proteins were eluted with wash buffer containing 50 mM glutathione or 200 mM imidazole, as appropriate. The protein samples were applied to a final size exclusion chromatography step before use. For GST-4xUb, a Superdex 200 column (GE Healthcare) was used, and for NDP52, a Superose six column (GE Healthcare) was used. The running buffer was 20 mM HEPES (pH 8.0), 200 mM NaCl and 1 mM TCEP. For purification of TSF-NDP52-mCherry, the transfected HEK GnTI cells were harvested and treated as ULK1 transfected HEK GnTI cells mentioned above. The supernatant was incubated with Strep-Tactin Sepharose (IBA Lifesciences) with gentle shaking for 2 hr at 4°C, and then subjected to a Strep tag affinity purification mentioned above. The protein samples were applied to a final size exclusion chromatography step using a Superose six column (GE Healthcare).

Negative stain electron microscopy collection and coiled-coil tracing {#s4-3}
---------------------------------------------------------------------

Grids were glow discharged in PELCO easiGlow for 25 s at 25 mAmps. Full length FIP200 labeled with an N terminal GST tag and a C terminal MBP tag was incubated on continuous carbon grids at 100 nM concentration. Protein was stained with 2% uranyl formate twice before drying and imaging. Samples were imaged with a T12 operating at 120 kV at a nominal magnification of 49,000x. This corresponds to 2.2 Å/pixel on a Gatan CCD 4k × 4 k camera. Data were collected at 60 e-/Å^2^ and single particles were manually selected within Relion. Particles were binned and extracted in a box size of 120 by 120 with 8.8 Å/pixel.

2D classification of the N and C terminal domains was carried out as follows. Relion LoG picker was used to pick the negative stain micrographs. 17,281 single particles were classified into 200 classes. Resolved class averages were selected based on the shape of the NTD dimer and the CTD trimeric density (the dimer Claw domain and 2 MBP tags). A second round of classification was performed to better resolve the class averages ([Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}).

Full length single particles were imported into FIJI ImageJ and traced using the plugin Simple Neurite Tracer yielding 117 individual tracks. Tracks were started at the beginning of the coiled-coil domain after the distinct NTD crescent shape and ended between the double MBP density at the C terminus. Tracking was checked for each single particle to ensure accuracy of the automatically determined path. End to end distances and total length measurements are shown as histograms.

Hydrogen-deuterium exchange mass spectrometry {#s4-4}
---------------------------------------------

FIP200 and NDP52 samples for HDX were concentrated to a 20 μM stock solution, ULK1 complex was concentrated to a 10 μM stock solution, while POPS/POPI SUVs (molar ratio = 1:1) were prepared as a 1 mM stock solution. The buffer used was 20 mM HEPES (pH 8.0), 200 mM NaCl and 1 mM TCEP. To prepare the ULK1c/NDP52 sample or ULK1c/SUV sample, 2 μL of ULK1c stock solution was mixed with 8 μL of NDP52 or SUV stock solution and then incubated at 23°C for 30 min. To prepare the FIP200 or ULK1c sample, 2 μL of protein stock was mixed with 8 μL of control buffer (20 mM HEPES (pH 8.0), 200 mM NaCl, 1 mM TCEP), and then incubated at 23°C for 30 min. Exchange was initiated by adding 90 μL of D~2~O buffer containing 20 mM HEPES (pH 8.0), 200 mM NaCl, 1 mM TCEP into 10 μL of protein mixture at 30°C. Exchange was carried out for 6 s, 60 s, 600 s, or 60000 s, and quenched at 0°C by the addition 100 μL of ice-cold quench buffer (400 mM KH~2~PO~4~/H~3~PO~4~, pH 2.2). The 60000 s sample served as the maximally labeled control. All HDX reactions were repeated three times. Quenched samples were injected into a chilled HPLC (Agilent) setup with in-line peptic digestion and desalting steps. The analytical column used was a Biobasic 8.5 μm KAPPA column (Fisher Scientific). The peptides were eluted with an acetonitrile gradient and electrosprayed into an Orbitrap Discovery mass spectrometer (Thermo Scientific) for analysis. To generate the gradient, solvent A was 0.05% TFA, while solvent B was 0.05% TFA in 90% acetonitrile. The elution method was as follows: 0--6 min: 10% B; 6--42 min: from 10% B to 55% B; 42--43 min: from 55% B to 90% B; 43--53 min: 90% B; 53--54 min: from 90% B to 10% B; 54--60 min: 10% B. The spray voltage was set at 3.4 kV, capillary temperature was set at 275°C, capillary voltage was set at 37 V and tube-lens was set at 120 V. As a control, unexchanged samples went through the same process, except that D~2~O was replaced by H~2~O.

To identify peptides, unexchanged samples were analyzed by tandem MS/MS analysis with the same HPLC method. Tandem MS/MS was performed using data dependent analysis, in which a cycle of one full-scan MS spectrum (m/z 200--2000) was acquired followed by MS/MS events (CID fragmentation). MS/MS was sequentially generated on the ten most intense ions selected from the full MS spectrum at a 35% normalized collision energy. The ion trap analyzer was used for MS2, activation time was 30 ms, and the dynamic exclusion was set at 30 s. For HDX mass analysis, only a full-scan MS spectrum was acquired, and the resolution was 30000. Database searches were performed with Proteome Discoverer 2.1 (Thermo Fisher Scientific) using the Sequest HT search engine to identify peptides. Raw data were searched against the small database containing all four components of ULK1 complex. The following search parameters were used: unspecific cleavage was used; precursor mass tolerance was set to ±10 ppm and fragment mass tolerance was set to ±0.6 Da. Target FDR was set to 1% as the filter cut-off for the identified peptides. For HDX analysis, mass analysis of the peptide centroids was performed using HDExaminer (Sierra Analytics), followed by manual verification for every peptide. The HDX-MS data are provided in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

ADP-Glo kinase assay {#s4-5}
--------------------

100 nM purified ULK1 complex was mixed with 5 μM ULKtide (SignalChem Biotech Inc), and incubated at room temperature for 1 hr. The reaction buffer was 20 mM HEPES pH 8.0, 200 mM NaCl, 2 mM MgCl~2~, 100 μM ATP, 20 mM Maltose and 1 mM TCEP. The reaction was terminated by adding an ATP-depletion reagent. Then a kinase detection reagent was added to convert ADP to ATP, which is used in a coupled luciferase reaction. The luminescent output was measured with a GloMax-Multi detection system (Promega) and was correlated with the kinase activity.

Pull-down assays {#s4-6}
----------------

For the fluorescence-based pulldown assay in [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}, purified fluorescent ULK1 complex (FIP200-MBP/EGFP-ATG13/EGFP-ATG101/ULK1) was mixed with purified GST-NDP52 or GST-4xUb and 10 μL Glutathione Sepharose 4B (GE Healthcare). The final buffer was 20 mM HEPES pH 8.0, 200 mM NaCl, 1 mM TCEP, 10 mM maltose and 1% Triton-X-100. The final protein concentration was 50 nM ULK1 complex and 1 μM GST-NDP52 or GST-4xUb. The final volume was 150 μL. The system was gently shaken for 1 hr at 23°C. The EGFP signal of the supernatant was measured before and after shaking to calculate the pull-down efficiency.

For the pulldown assay in [Figure 2E](#fig2){ref-type="fig"}, purified fluorescent FIP200(EGFP-FIP200-MBP) or ULK1 complex (EGFP-FIP200-MBP/ATG13/ATG101/ULK1) was mixed with purified GST-NDP52 at the indicated concentrations.

For the pulldown assay in [Figures 2F](#fig2){ref-type="fig"} and 10 mL of HEK293-GnT1 suspension cells were transfected at the concentration of 2--2.5 × 10^6^/mL and harvested after 48 hr. The harvested cells were pelleted at 500 x g for 8 min at 4°C, and then washed with 5 mL PBS once. The pellets were then lysed with 1 mL lysis buffer containing 50 mM Tris-HCl pH 7.4, 200 mM NaCl, 2 mM MgCl~2~, 1 mM TCEP, 1% Triton X-100, 10% Glycerol and protease inhibitors (Roche) before being cleared at 12000 rpm for 10 min at 4°C. The supernatant was then incubated with 20 μL Glutathione Sepharose 4B (GE Healthcare) or Amylose resin (New England Biolabs) with gentle shaking for 8 hr at 4°C. The protein-bound resin was washed with 1 mL lysis buffer three times, and then eluted with 60 μl elution buffer containing 50 mM glutathione or 50 mM maltose, respectively. The eluted proteins were applied to SDS--PAGE for analysis.

Liposome sedimentation assays {#s4-7}
-----------------------------

POPI, POPS, POPE and POPC from Avanti Polar Lipids, Inc were dissolved in chloroform. The chloroform was removed by overnight incubation under vacuum. Lipids were rehydrated in 20 mM HEPES pH 8.0, 200 mM NaCl, 1 mM TCEP and 50 mM Maltose for 30 min on ice and then resuspended by vigorous vortexing. Small unilamellar vesicles (SUVs) were prepared by sonication on ice until the solution appeared clear. Two kinds of SUV were prepared. PS/PI SUV is comprised of 50% POPS and 50% POPI, while PC/PE SUV is comprised of 50% POPC and 50% POPE. The protein and SUV were mixed and incubated at room temperature for 30 min. The final concentration of protein is 1 μM and the final concentration of liposomes was 100 μM. The final buffer was 20 mM HEPES pH 8.0, 200 mM NaCl, 1 mM TCEP and 10 mM Maltose. The liposomes were pelleted in an ultracentrifuge (TLA100 rotor) for 45 min at 50,000 rpm, and the presence of protein in the pellet and supernatant fractions was analyzed by SDS-PAGE.

Preparation of giant unilamellar vesicles (GUVs) {#s4-8}
------------------------------------------------

GUVs were prepared by hydrogel-assisted swelling as described previously ([@bib5]). Polyvinyl alcohol (PVA) with a molecular weight of 145,000 (Millipore) was used as hydrogel substrate. 300 μL of 5% (w/w) PVA solution was spin coated onto a plasma-cleaned coverslip of 25 mm diameter. The coated coverslip was placed for 30 min in a heating incubator at 60°C to dry the PVA film. A lipid mixture with a molar composition of 64.8% DOPC, 20% DOPE, 10% POPI, 5% DOPS and 0.2% Atto647N DOPE at 1 mg/ml was spread uniformly onto the PVA film. The lipid-coated coverslip was then put under vacuum overnight to evaporate the solvent. 300 μL 400 mOsm sucrose solution was used for swelling for 1 hr at room temperature, and the vesicles were then harvested and used immediately.

Membrane protein recruitment -- GUV assay {#s4-9}
-----------------------------------------

The reactions were set up in an eight-well observation chamber (Lab Tek) at room temperature. The chamber was coated with 5 mg/ml β casein for 30 min and washed three times with reaction buffer (20 mM HEPES at pH 8.0, 190 mM NaCl and 1 mM TCEP). A final concentration of 10 µM GST-4xUb, 1 µM NDP52, and 100 nM GFP-FIP200 or GFP-ULK1 complex was used for all reactions unless otherwise specified. 15--20 µL GUVs were added to initiate the reaction in a final volume of 150 µL. After 5 min incubation, during which we picked random views for imaging, time-lapse images were acquired in multitracking mode on a Nikon A1 confocal microscope with a 63 × Plan Apochromat 1.4 NA objective. Three biological replicates were performed for each experimental condition. Identical laser power and gain settings were used during the course of all conditions.

Microscopy-based bead protein-protein interaction assay {#s4-10}
-------------------------------------------------------

A mixture of 1 µM GST-NDP52 and 100 nM GFP-ULK1 complex was incubated with 10 µL Glutathione Sepharose beads (GE Healthcare) in a reaction buffer containing 20 mM HEPES at pH 8.0, 200 mM NaCl and 1 mM TCEP. After incubation at room temperature for 30 min, the beads were washed three times, suspended in 120 µL reaction buffer, and then transferred to the observation chamber for imaging. Images were acquired on a Nikon A1 confocal microscope with a 63 × Plan Apochromat 1.4 NA objective. Three biological replicates were performed for each experimental condition.

Image quantification {#s4-11}
--------------------

GUV images were analyzed using a custom script implemented in Python 3.6 (<https://github.com/Hurley-Lab/FIP-NDP52-paper>; [@bib12]; copy archived at <https://github.com/elifesciences-publications/FIP-NDP52-paper>). First, to obtain the outline of all the vesicles within a field of view, images were segmented into regions corresponding to local maxima of the membrane fluorescence channel, which were defined by applying an Otsu threshold to the differences between local maxima and minima. Then, binding of fluorescently labeled proteins was quantified by taking the mean value of these segmented pixels in the fluorescent protein channel. Background was calculated as the average of the vesicle-internal background and the vesicle-external background and subtracted from the fluorescence signal. The intensity trajectories of multiple fields of view were then obtained frame by frame. Multiple intensity trajectories were calculated, and the average and standard deviation calculated and reported.

For quantification of bead binding, the outline of individual beads was manually defined based on the bright field channel. The intensity threshold was calculated by the average intensities of pixels inside and outside of the bead and then intensity measurements of individual bead were obtained. Averages and standard deviations were calculated among the measured values per each condition and plotted in a bar graph.
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###### Table S1.

Statistics of HDX differences for [Figure 2D](#fig2){ref-type="fig"} The peptides covering residue 800--1250 of FIP200 are listed, and the number of repeat and the sequence of each peptides are provided. The statistical test of HDX differences employed is paired T-test. P value less than 0.05 is highlighted in red, representing significant difference between ULK1 complex and ULK1 complex with NDP52 samples.

###### HDX-MS Data Sets The summary tables of HDX data for each protein in ULK1 complex are provided, and the original peptide pool results are included.

Data availability {#s7}
=================

All data generated in this study are included in the manuscript and supporting files. HDX-MS data are included as Supplementary Data Set 1.
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**Acceptance summary:**

This paper employs biophysical approaches to examine membrane binding of NDP52, a protein involved in selective autophagy. The authors propose a new membrane binding mechanism involving the coiled-coil of NDP52. This represents a new mechanism that may collaborate with ubiquitin binding by NDP52 to capture autophagic cargo.

**Decision letter after peer review:**

Thank you for submitting your article \"The autophagy adaptor NDP52 and the FIP200 coiled-coil allosterically activate ULK1 complex membrane recruitment\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Wade Harper as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Suzanne Pfeffer as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is \"in revision at *eLife*\". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

Summary:

This paper describes biophysical and structural studies on purified, full length FIP200 in complex with its other binding partners, including NDP52 (a well-known ubiquitin binding autophagy receptor). The results presented in this manuscript corroborate prior results from the Hurley lab demonstrating a \"C-Shaped\" N-terminal dimer that acts as a scaffold of ULK1-ATG13-ATG101, while the C-terminal claw region engages receptor molecules such as NDP52 and p62. Furthermore, Shi et al. conclude that a coiled-coil region within FIP200 undergoes a dynamic conformational change upon binding with the receptor molecule NDP52, increasing its affinity for FIP200 towards membranes. They propose that NDP52 binding to the surface to cargo elicits a conformational change in the FIP200, increasing its propensity to bind to membranes and drives the local clustering of the ULK1 kinase leading to its autoactivation and the induction of autophagy.

While the reviewers feel that the work is of high quality and is potentially appropriate for publication in *eLife*, the consensus after extensive discussion among the reviewers and the senior editor is that core elements of the proposed model are not fully supported by the data presented thus far. This has to do primarily with the relative roles/contributions of coiled-coli domains in FIP200 and NDP52 for association with membranes, and whether there is a key role for allostery in the mechanism of membrane binding. Another weakness in the paper is that the work primarily employs liposomes, rather than intact membranes, and there isn\'t data supporting the role for these structural elements in autophagy within cells. Given this, we are offering the possibility of a significant revision, but without the normal time constraints, due to COVID-19 related limitations on lab access.

Essential revisions:

The reviewers would like to see:

1\) A better understanding of the structural features within the coiled-coils that facilitate membrane binding.

2\) An analysis of the interactions with biological membranes rather than liposomes would be important in further validating the model.

3\) A better understanding of the allostery mechanism is needed. It is often assumed that regions predicted to be \"coiled-coil\" form a typical helical dimeric assembly of α-helices. In such case, the \"hydrophobic residues\", which are assumed to be buried in the dimeric interface, twists along the long axis of the coiled-coil. The MR reported in this study is fairly long (over 150 residues). Although association of short coiled-coil domains are known to associate with membranes, it is harder to see how an extended helix might do this, and so the question is whether this coiled-coil undergoes an alteration in structure (e.g. melting) that is in some way coupled with the allostery (or not). If so, that could cause liposome binding, as shown in Figure 3D. Again, Figure 3D\'s data are without NDP52. As such, the data does not directly demonstrate the suggested binding mode (hydrophobic residues are exposed upon allosteric conformational change, and those residues bind to membranes).

After discussion, we concluded that perhaps analysis of mutants in cells is beyond the scope of this heavily biophysical analysis. However, one aspect that is unclear concerns the conclusion that NDP52 is effectively recruited to membranes on its own or together with FIP200. For example, in the context of mitophagy, mutations in the ubiquitin binding domain of NDP52 abolish recruitment to the mitochondrial outermembrane downstream of parkin activation in cells. It is difficult to see how the intrinsic membrane binding of NDP52 could be operative in this context as the core mechanism of recruitment, given the ubiquitin binding dependence. Although OPTN is the main adaptor in this form of selective autophagy, NDP52 plays a partially redundant role and cells only expressing NDP52 as the ubiquitin binding autophagy adaptor can support mitophagy. So this aspect of the model for direct and biologically relevant membrane as the primary mechanism for membrane recruitment doesn\'t precisely fit with prior data and it may be necessary to discuss how membrane binding may be relevant in the context of other mechanisms that place NDP52 adjacent to the membrane. Might the primary recruitment mechanism be through ubiquitin, but then the membrane interactions serve to orient the molecules on the membrane surface for optimal downstream functions?

Reviewer \#1:

Autophagy is driven by the action of the central and highly conserved ULK1 complex which comprises of the Serine/Threonine kinase ULK1, the large scaffolding protein FIP200, and the accessory proteins ATG13 and ATG101. Additionally, cargo sequestration in autophagy is bought about by the binding of autophagy \"receptor\" molecules to the surface of cargo and helps recruit the ULK1 complex via direct interactions to promote their degradation.

Structural studies on this complex (specifically FIP200) have been limited, largely in part due the size and the prevalence of an Intrinsically disordered region in the center of the protein. Recently, the Hurley lab have made strides in the understanding of three-dimensional architecture of this complex by ascertaining the structure of the N-terminal(NTD) and extreme C-terminal regions(Claw) of FIP200. In this paper, Shi and colleagues describe another advancement in the study of this complex by biophysical and structural studies on purified, full length FIP200 in complex with its other binding partners. The results presented in this manuscript corroborate prior results from the Hurley lab demonstrating a \"C-Shaped\" N-terminal dimer that acts as a scaffold of ULK1-ATG13-ATG101, while the C-terminal claw region engages receptor molecules such as NDP52 and p62. Furthermore, Shi et al. demonstrate that a coiled-coil region within FIP200 undergoes a dynamic conformational change upon binding with the receptor molecule NDP52, increasing its affinity for FIP200 towards membranes. Therefore, autophagy receptor binding to the surface to cargo elicits a conformational change in the FIP200, increasing its propensity to bind to membranes and drives the local clustering of the ULK1 kinase leading to its autoactivation and the induction of autophagy.

Overall this is a well-executed and presented study and would be suitable for publication once the following points are addressed.

1\) While the biophysical assays are relatively convincing, one obvious drawback is the absence of any functional autophagy assays to monitor if this receptor-mediated conformational change is actually physiologically important. The most obvious experiment in this regard would be to add back the FIP200 (deleted membrane region) and monitor any form of autophagy. However, given the state of affairs due to the ongoing COVID19 pandemic I would say that this experiment is not critical, but if performed would significantly bolster the conclusions of this paper.

2\) The HDX graphs were not always clear to this reader. For example, in Figure 1C the blue and grey colors need to be assigned to the relevant sample. Additionally, the number of repeats performed here and in every experiment presented should be stated.

3\) The increase in the FIP200 residues 800-1250 (2D) after NDP52 doesn\'t seem significant by the authors own cut-offs (\> or \<10%), nevertheless this region appears to the important for membrane binding.

4\) Figure 2F is lacking input controls to show that the levels of MBP-NDP52 and GST FIP200 in cells are equal.

Reviewer \#2:

In this manuscript from Hurley and colleagues, the authors describe for the first time the structure of the full-length FIP200 protein including its \~75 nm long coiled-coil domain, and then explore how this region of the protein contributes to the membrane targeting of FIP200 and of its cognate kinase, ULK1. Their principle discoveries are that the coiled coil includes a region that can interact with acidic lipids PI and/or PS, that this motif can adopt a range of structures (fully elongated or bent back on itself) and that there is no allosteric communication between the opposite termini of the coiled-coil, thus for example cargo-binding does not directly alter ULK1 interactions. Furthermore, the membrane interaction is augmented under conditions of multimerization, such as occurs when FIP200 is engaged with the oligomeric cargo adaptor NDP52 and polyUB.

The strength of the paper is the excellent in vitro biochemistry and biophysics. The authors use deuterium exchange to establish regions on FIP200 involved in ULK1, NDP52 and membrane binding. They use electron microscopy to develop a model of the full-length protein (and protein complex). GUV recruitment assays confirm that membrane binding of ULK1 depends upon FIP200 and NDP52/Ub, and that this membrane binding is augmented by the motif in the coiled-coil domain. Further, membrane binding leads to localized domains of ULK1 protein, consistent with the association of ULK1 to an oligomerizing cargo/cargo-adaptor complex. The design and chronology of experiments are logical and each is well controlled.

1\) I have only one relatively significant concern with the structure of the narrative. The authors pose the general question of how FIP200 organizes ULK1 on membranes and attempt to address this question through most of the paper without acknowledging that NDP52 itself can and does bind membranes. This point, previously published, is finally addressed at the end of the Results, but it fundamentally changes the way the results should be considered. In the Discussion they say \" The data presented here suggest that the membrane binding region (MR) in the N terminal portion of FIP200 CC is the major membrane binding site responsible for the first ULK1 complex membrane recruitment event in autophagy \" and \"Our data suggest a model wherein NDP52 binding to the Cterminus of FIP200 CC promotes lipid binding at the MR, so allowing a tether to be formed between cargo and the ER subdomain destined to become the omegasome.\" However, their GUV recruitment assay (Figure 5 and Figure 5---figure supplement 1) strongly implies that although the membrane-binding motif they have described on FIP200 can augment membrane binding, NDP52 is still largely sufficient and a/the principle driver of membrane targeting. This element of the model should be more fully described and the existing literature on the role of NDP52 in targeting these complexes specifically to membranes should be introduced early.

Reviewer \#3:

The authors dissect protein-protein interactions within the NDP52-ULK1 complex and its membrane interaction using HDX and identify a membrane-interacting region in the coiled-coil domain of its component FIP200. They show the ULK1 complex is recruited to GUV membranes through the identified membrane-binding region, and this membrane recruitment is activated by NDP52. Because NDP52 binds to another region in the coiled-coil domain of FIP200, they conclude that NDP52 allosterically activates the membrane-binding region of the FIP200. This in vitro study is performed carefully, and the presented data appear to be of high quality. Identification of the membrane-interacting region of FIP200 is valuable for the autophagy field and would help future work toward the elucidation of the role of FIP200 in autophagy. However, it seems that the allosteric activation is not fully supported by the data and the work struggles to establish the biological significance of this membrane-binding activity by FIP200.

1\) It is not clear how the FIP200-mediated membrane association fits in the biological event (selective autophagy). There seem to be several candidate membranes that FIP200 might associate with: the membrane of the targets (bacteria/mitochondria), the ER, the omegasome, the autophagosome/phagophore. However, which of these is the bona fide membrane target of FIP200 is not clear, making it difficult to relate the findings of this work to the mechanism of selective autophagy. NDP52 is also shown to be capable of associating with membranes, which complicates the interpretation. How are the roles of these membrane associations by FIP200 and NDP52 related?

2\) The coiled-coil domain is suggested to associate with membranes through hydrophobic residues exposed upon NDP52 binding. This is a very interesting and thoughtful model deduced from a careful interpretation of the HDX data. However, as hydrophobic residues could bind to many things, this explanation alone is probably not sufficient to convince that the observed membrane-binding is biological. More detailed mechanism of the membrane association could help clarify this. Is the MR predicted to form a typical parallel coiled-coil dimer? If so, would a structural model provide insights into the mechanism of membrane binding?

3\) The authors suggest that NDP52 allosterically activates the membrane binding by FIP200. However, FIP200 is suggested to have weak and intrinsic membrane-binding activity (in the absence of NDP52) (Figure 3D). The overall membrane binding could be enhanced through multivalent FIP200-membrane interactions created by GST-4xUb-mediated clustering. Thus, it seems that the membrane-binding data of the NDP52-ULK1 complex can be explained without invoking such allosteric activation. The NDP52-membrane interactions would also become multivalent in the presence of GST-4xUb so that they would also contribute to the membrane recruitment of the overall complex. Thus, with two membrane-binding domains and clustering, it seems to be not straightforward to determine the magnitude of allosteric activation in the presented data.

4\) NDP52 alone does not seem to recruit FIP200 to membranes. However, NDP52 alone is shown to be capable of destabilizing the MR. GST-NDP52 enhances the FIP200 membrane association but only modestly. Thus, these data seem to suggest that the membrane-binding affinity of \"activated MR\" is very low. If hydrophobic residues in such a long region of the coiled-coil were exposed to interact with membranes, as suggested, shouldn\'t the affinity be higher?

5\) Direct evidence for the allosteric activation is lacking. While structural information is limited to at a low-resolution, the membrane-binding region and NDP52 binding site are both in the coiled-coil. Thus, it may be possible to design and create a mutant FIP200 that can bind to NDB52 but not to membranes without touching MR and NDP52 binding sites directly. Such a mutant protein will be strong support for the suggested allostery.

6\) Is the mechanism by which NDP52 associates with membranes known? The authors should create an NDP52 construct that can bind to FIP200 but not to membranes and use it in their ULK1/FIP200 membrane recruitment assays to remove the contribution of NDP52-membrane association.

7\) Full-length FIP200 should be included in the sedimentation assay in Figure 3D as it would clarify whether the full-length and the truncated proteins are different in membrane binding.

8\) An MR-only construct should be tested for membrane binding using sedimentation assays and GUV assays to clarify whether the activity of the MR is intrinsically suppressed or not. The MR is said to be not electropositive, but in Figure 3, the C-terminal FIP200 construct shows a better binding with negatively charged liposomes. An MR-only construct might reveal the differences between the MR and the entire CTD. Is the CTD overall electropositive?

9\) The oligomeric state of NDP52 should be examined as it has a coiled-coil domain that may oligomerize.

10\) The KD between NDP52 and FIP200 coiled-coil would be helpful for understanding the contribution of FIP200 in membrane association if available.

11\) It may be helpful to present the raw HDX protection profiles (not differences between two samples) as supplements to show protection levels of each samples. Are the coiled-coil regions well protected in the absence of NDP52/liposomes?

10.7554/eLife.59099.sa2

Author response

> Essential revisions:
>
> The reviewers would like to see:
>
> 1\) A better understanding of the structural features within the coiled-coils that facilitate membrane binding.

The HDX data are consistent with melting of the coiled coil. Our model is that when bound to the membrane, these regions are not coiled coils at all, but rather are unfolded. We are not sure how the reviewers would propose that we should determine the structural feature of unfolded regions protruding into the membrane, beyond the HDX we already provided. These are too disordered for crystallography and too small and dynamic for cryo-EM. HDX is ideally suited to exploring this type of system, and indeed we consider it to be the gold standard for this type of question. This is the reason we focused the paper on these data. We have added a new Figure 6 to be more clear about what we think is happening to the coiled coils.

> 2\) An analysis of the interactions with biological membranes rather than liposomes would be important in further validating the model.

We appreciate and concur with the comment below that \"analysis of mutants in cells is beyond the scope\" of our study.

> 3\) A better understanding of the allostery mechanism is needed. It is often assumed that regions predicted to be \"coiled-coil\" form a typical helical dimeric assembly of α-helices. In such case, the \"hydrophobic residues\", which are assumed to be buried in the dimeric interface, twists along the long axis of the coiled-coil. The MR reported in this study is fairly long (over 150 residues). Although association of short coiled-coil domains are known to associate with membranes, it is harder to see how an extended helix might do this, and so the question is whether this coiled-coil undergoes an alteration in structure (e.g. melting) that is in some way coupled with the allostery (or not).

Yes, the HDX data are most consistent with melting. We have made this more explicit in the new Figure 6.

> If so, that could cause liposome binding, as shown in Figure 3D. Again, Figure 3D\'s data are without NDP52. As such, the data does not directly demonstrate the suggested binding mode (hydrophobic residues are exposed upon allosteric conformational change, and those residues bind to membranes).

The liposome sedimentation in Figure 3D was intended as a gross mapping of the membrane binding to the C-terminal as opposed to N-terminal data. Our conclusions about allostery build on this and rely principally on the HDX data and GUV reconstitutions. Certainly these conclusions could not have been drawn solely based on the data in Figure 3D.

> After discussion, we concluded that perhaps analysis of mutants in cells is beyond the scope of this heavily biophysical analysis. However, one aspect that is unclear concerns the conclusion that NDP52 is effectively recruited to membranes on its own or together with FIP200. For example, in the context of mitophagy, mutations in the ubiquitin binding domain of NDP52 abolish recruitment to the mitochondrial outermembrane downstream of parkin activation in cells. It is difficult to see how the intrinsic membrane binding of NDP52 could be operative in this context as the core mechanism of recruitment, given the ubiquitin binding dependence. Although OPTN is the main adaptor in this form of selective autophagy, NDP52 plays a partially redundant role and cells only expressing NDP52 as the ubiquitin binding autophagy adaptor can support mitophagy. So this aspect of the model for direct and biologically relevant membrane as the primary mechanism for membrane recruitment doesn\'t precisely fit with prior data and it may be necessary to discuss how membrane binding may be relevant in the context of other mechanisms that place NDP52 adjacent to the membrane. Might the primary recruitment mechanism be through ubiquitin, but then the membrane interactions serve to orient the molecules on the membrane surface for optimal downstream functions?

Hopefully the new Figure 6 and associated discussion explains how we think our results fit into the context of the known linkage between Ub, NDP52, and FIP200. See further discussion below in the responses to individual reviewers.

> Reviewer \#1:
>
> Autophagy is driven by the action of the central and highly conserved ULK1 complex which comprises of the Serine/Threonine kinase ULK1, the large scaffolding protein FIP200, and the accessory proteins ATG13 and ATG101. Additionally, cargo sequestration in autophagy is bought about by the binding of autophagy \"receptor\" molecules to the surface of cargo and helps recruit the ULK1 complex via direct interactions to promote their degradation.
>
> Structural studies on this complex (specifically FIP200) have been limited, largely in part due the size and the prevalence of an Intrinsically disordered region in the center of the protein. Recently, the Hurley lab have made strides in the understanding of three-dimensional architecture of this complex by ascertaining the structure of the N-terminal(NTD) and extreme C-terminal regions(Claw) of FIP200. In this paper, Shi and colleagues describe another advancement in the study of this complex by biophysical and structural studies on purified, full length FIP200 in complex with its other binding partners. The results presented in this manuscript corroborate prior results from the Hurley lab demonstrating a \"C-Shaped\" N-terminal dimer that acts as a scaffold of ULK1-ATG13-ATG101, while the C-terminal claw region engages receptor molecules such as NDP52 and p62. Furthermore, Shi et al. demonstrate that a coiled-coil region within FIP200 undergoes a dynamic conformational change upon binding with the receptor molecule NDP52, increasing its affinity for FIP200 towards membranes. Therefore, autophagy receptor binding to the surface to cargo elicits a conformational change in the FIP200, increasing its propensity to bind to membranes and drives the local clustering of the ULK1 kinase leading to its autoactivation and the induction of autophagy.
>
> Overall this is a well-executed and presented study and would be suitable for publication once the following points are addressed.
>
> 1\) While the biophysical assays are relatively convincing, one obvious drawback is the absence of any functional autophagy assays to monitor if this receptor-mediated conformational change is actually physiologically important. The most obvious experiment in this regard would be to add back the FIP200 (deleted membrane region) and monitor any form of autophagy. However, given the state of affairs due to the ongoing COVID19 pandemic I would say that this experiment is not critical, but if performed would significantly bolster the conclusions of this paper.

Thanks for your understanding.

> 2\) The HDX graphs were not always clear to this reader. For example, in Figure 1C the blue and grey colors need to be assigned to the relevant sample. Additionally, the number of repeats performed here and in every experiment presented should be stated.

Thanks for the suggestion. We have added this information to the figure legend.

> 3\) The increase in the FIP200 residues 800-1250 (2D) after NDP52 doesn\'t seem significant by the authors own cut-offs (\> or \<10%), nevertheless this region appears to the important for membrane binding.

The 10% cut-off was arbitrary and reflected a cautious figure well in excess of the actual threshold of significance. For the region in question, we have added a table of p-values, which is the new Table S2. We have not done this throughout as the other effects, such as NDP52 binding, are so large and unambiguous.

> 4\) Figure 2F is lacking input controls to show that the levels of MBP-NDP52 and GST FIP200 in cells are equal.

In this experiment, MBP-NDP52 and GST-FIP200(1274-C) were co-expressed in HEK cells. The cell lysate was divided into two fractions. One for MBP pulldown and the other for GST pulldown assay. Therefore, the MBP-NDP52 bands in the MBP pulldown and GST-FIP200 intensity in the GST serve as input controls, and do show equal amounts of MBP-NDP52 and GST-FIP200 in all samples.

> Reviewer \#2:
>
> In this manuscript from Hurley and colleagues, the authors describe for the first time the structure of the full-length FIP200 protein including its \~75 nm long coiled-coil domain, and then explore how this region of the protein contributes to the membrane targeting of FIP200 and of its cognate kinase, ULK1. Their principle discoveries are that the coiled coil includes a region that can interact with acidic lipids PI and/or PS, that this motif can adopt a range of structures (fully elongated or bent back on itself) and that there is no allosteric communication between the opposite termini of the coiled-coil, thus for example cargo-binding does not directly alter ULK1 interactions. Furthermore, the membrane interaction is augmented under conditions of multimerization, such as occurs when FIP200 is engaged with the oligomeric cargo adaptor NDP52 and polyUB.
>
> The strength of the paper is the excellent in vitro biochemistry and biophysics. The authors use deuterium exchange to establish regions on FIP200 involved in ULK1, NDP52 and membrane binding. They use electron microscopy to develop a model of the full-length protein (and protein complex). GUV recruitment assays confirm that membrane binding of ULK1 depends upon FIP200 and NDP52/Ub, and that this membrane binding is augmented by the motif in the coiled-coil domain. Further, membrane binding leads to localized domains of ULK1 protein, consistent with the association of ULK1 to an oligomerizing cargo/cargo-adaptor complex. The design and chronology of experiments are logical and each is well controlled.
>
> 1\) I have only one relatively significant concern with the structure of the narrative. The authors pose the general question of how FIP200 organizes ULK1 on membranes and attempt to address this question through most of the paper without acknowledging that NDP52 itself can and does bind membranes. This point, previously published, is finally addressed at the end of the Results, but it fundamentally changes the way the results should be considered. In the Discussion they say \" The data presented here suggest that the membrane binding region (MR) in the N terminal portion of FIP200 CC is the major membrane binding site responsible for the first ULK1 complex membrane recruitment event in autophagy \" and \"Our data suggest a model wherein NDP52 binding to the Cterminus of FIP200 CC promotes lipid binding at the MR, so allowing a tether to be formed between cargo and the ER subdomain destined to become the omegasome.\" However, their GUV recruitment assay (Figure 5 and Figure 5---figure supplement 1) strongly implies that although the membrane-binding motif they have described on FIP200 can augment membrane binding, NDP52 is still largely sufficient and a/the principle driver of membrane targeting. This element of the model should be more fully described and the existing literature on the role of NDP52 in targeting these complexes specifically to membranes should be introduced early.

The membrane binding by the MR mutant is reduced by about 2.5-fold. Put in perspective, the MR accounts for more than half of the bound proportion. Given that collectively FIP200 and NDP52 comprise an assembly of over 2000 amino acids, it is not surprising that there are some additional contributions. We believe the residual membrane binding is due to a combination of smaller contributions from membrane binding sites on other parts of FIP200 and on NDP52. There is only one paper that we are aware of that previously proposed NDP52 bound to membranes, that of H. Yu et al. (2019). This paper concerned microtubule regulation in mitosis, not autophagy. It was found that NDP52 only bound to synthetic liposomes containing phosphatidic acid (PA) in that study. A putative PA sequence was reported in this study. We have not been able to reproduce these results in the GUV system. Using PA-containing GUVs, we observed a limited degree of binding by wild-type NDP52 or the putative PA-binding mutant (Author response 1). Given the uncertain relationship of the putative PA binding to autophagy and our inability to reproduce the effect in the GUV system, it is not clear how the Yu et al. data relate to ours or to autophagy, and we thought it best to remove the discussion of the Yu paper.

![NDP52 binds weakly to PA-containing GUVs.\
Binding is unaffected by mutation of the putative PA binding sequence of Yu et al.](elife-59099-resp-fig1){#sa2fig1}

> Reviewer \#3:
>
> The authors dissect protein-protein interactions within the NDP52-ULK1 complex and its membrane interaction using HDX and identify a membrane-interacting region in the coiled-coil domain of its component FIP200. They show the ULK1 complex is recruited to GUV membranes through the identified membrane-binding region, and this membrane recruitment is activated by NDP52. Because NDP52 binds to another region in the coiled-coil domain of FIP200, they conclude that NDP52 allosterically activates the membrane-binding region of the FIP200. This in vitro study is performed carefully, and the presented data appear to be of high quality. Identification of the membrane-interacting region of FIP200 is valuable for the autophagy field and would help future work toward the elucidation of the role of FIP200 in autophagy. However, it seems that the allosteric activation is not fully supported by the data and the work struggles to establish the biological significance of this membrane-binding activity by FIP200.
>
> 1\) It is not clear how the FIP200-mediated membrane association fits in the biological event (selective autophagy). There seem to be several candidate membranes that FIP200 might associate with: the membrane of the targets (bacteria/mitochondria), the ER, the omegasome, the autophagosome/phagophore. However, which of these is the bona fide membrane target of FIP200 is not clear, making it difficult to relate the findings of this work to the mechanism of selective autophagy. NDP52 is also shown to be capable of associating with membranes, which complicates the interpretation. How are the roles of these membrane associations by FIP200 and NDP52 related?

The membrane source for autophagosome biogenesis is a long-standing question in the field, but is not the focus of this study. Most thinking in the field is that the ER is the donor in most cases, but that in some situations there can be other sources. We have used synthetic lipid mixtures that are intended to mimic the ER. However, the increase in generic membrane affinity should contribute regardless of the specific organelle, so these findings should be relevant to any FIP200-dependent form of autophagy even if the membrane source were not the ER.

The strong MR phenotype shown with improved signal to noise in the revised Figure 5 emphasizes that the FIP200 MR is predominantly driving membrane binding, with smaller contributions from NDP52 and probably from the FIP200 NTD.

> 2\) The coiled-coil domain is suggested to associate with membranes through hydrophobic residues exposed upon NDP52 binding. This is a very interesting and thoughtful model deduced from a careful interpretation of the HDX data. However, as hydrophobic residues could bind to many things, this explanation alone is probably not sufficient to convince that the observed membrane-binding is biological. More detailed mechanism of the membrane association could help clarify this. Is the MR predicted to form a typical parallel coiled-coil dimer? If so, would a structural model provide insights into the mechanism of membrane binding?

We think HDX is the gold standard experiment for studying helix melting events, which this appears to be. No better experiment is obvious to us. We have tried to be clearer about the model in the new Figure 6.

> 3\) The authors suggest that NDP52 allosterically activates the membrane binding by FIP200. However, FIP200 is suggested to have weak and intrinsic membrane-binding activity (in the absence of NDP52) (Figure 3D). The overall membrane binding could be enhanced through multivalent FIP200-membrane interactions created by GST-4xUb-mediated clustering. Thus, it seems that the membrane-binding data of the NDP52-ULK1 complex can be explained without invoking such allosteric activation. The NDP52-membrane interactions would also become multivalent in the presence of GST-4xUb so that they would also contribute to the membrane recruitment of the overall complex. Thus, with two membrane-binding domains and clustering, it seems to be not straightforward to determine the magnitude of allosteric activation in the presented data.

We agree with the reviewer that clustering and conformational changes likely work together to increase membrane affinity, as depicted in the new Figure 6.

> 4\) NDP52 alone does not seem to recruit FIP200 to membranes. However, NDP52 alone is shown to be capable of destabilizing the MR. GST-NDP52 enhances the FIP200 membrane association but only modestly. Thus, these data seem to suggest that the membrane-binding affinity of \"activated MR\" is very low. If hydrophobic residues in such a long region of the coiled-coil were exposed to interact with membranes, as suggested, shouldn\'t the affinity be higher?

In HDX assays, NDP52 and ULK1 complex are at 16 and 2 μM concentration respectively, so as to saturate binding and ensure we are studying the bound form. In the GUV assays, the ULK1 complex is at 100 nM concentration, to avoid saturating the imaging and lipid binding in the absence of activation. The destabilization of the MR by NDP52 in the absence of lipids is thus observed at a 20-fold higher concentration as compared to the GUV imaging experiment. Since binding to GUVs appears saturating at 100 nM in the presence of NDP52 (but not absence) it would appear that the activated form does in fact bind tightly to membranes.

> 5\) Direct evidence for the allosteric activation is lacking. While structural information is limited to at a low-resolution, the membrane-binding region and NDP52 binding site are both in the coiled-coil. Thus, it may be possible to design and create a mutant FIP200 that can bind to NDB52 but not to membranes without touching MR and NDP52 binding sites directly. Such a mutant protein will be strong support for the suggested allostery.

We are not sure what this mutation would be. It would certainly be nice to have such a mutant.

> 6\) Is the mechanism by which NDP52 associates with membranes known? The authors should create an NDP52 construct that can bind to FIP200 but not to membranes and use it in their ULK1/FIP200 membrane recruitment assays to remove the contribution of NDP52-membrane association.

See the [Author response image 1](#sa2fig1){ref-type="fig"}. We constructed what had been reported to be such a mutant based on Yu et al. Cell Research (2019), however the weak binding was unaffected by the putative PA binding motif in this paper. To delve further into the question of whether NDP52 actually binds membranes on its own, and if so, how, would in our view be a different study, one focused on NDP52, as opposed to FIP200, and so beyond the scope of the present work.

The re-analysis of the MR mutant GUV data in Figure 5, showing a strong phenotype with improved signal to noise, should hopefully help allay the reviewer\'s concern. Clearly the MR is the single largest driver for membrane affinity. The critical roles of NDP52 are to target FIP200 to sites of autophagy initiation and to trigger the conformational change in FIP200.

> 7\) Full-length FIP200 should be included in the sedimentation assay in Figure 3D as it would clarify whether the full-length and the truncated proteins are different in membrane binding.

Full length FIP200 aggregates easily and is found in the pellet after ultracentrifugation even in the absence of lipids, making this experiment difficult to interpret.

> 8\) An MR-only construct should be tested for membrane binding using sedimentation assays and GUV assays to clarify whether the activity of the MR is intrinsically suppressed or not. The MR is said to be not electropositive, but in Figure 3, the C-terminal FIP200 construct shows a better binding with negatively charged liposomes. An MR-only construct might reveal the differences between the MR and the entire CTD. Is the CTD overall electropositive?

Yes, the CTD overall is electropositive. A detailed characterization of the membrane binding properties of the isolated MR fragment would be potentially interesting but it is somewhat beyond the scope of this current paper. The main innovation in the current study is the biochemistry of full-length FIP200 and the complex ULK1 complex, which has been difficult to study in the past because it has been so hard to express in quantity. The conclusions of the study are fully supported we believe without this extension.

> 9\) The oligomeric state of NDP52 should be examined as it has a coiled-coil domain that may oligomerize.

We would be concerned about changing the scope and focus of the paper from FIP200 to NDP52 and have therefore refrained from adding these data, which we do not feel are needed to support the conclusions. This would be interesting as a future direction in a research program more focused on the autophagy adaptors as opposed to the core complexes.

> 10\) The KD between NDP52 and FIP200 coiled-coil would be helpful for understanding the contribution of FIP200 in membrane association if available.

These data are not available in our lab. This is another experiment that would add useful data to the field, but the focus on biochemistry of subcomponents of the system is in our view a sidelight that distracts from the main message and innovation in the study.

> 11\) It may be helpful to present the raw HDX protection profiles (not differences between two samples) as supplements to show protection levels of each samples. Are the coiled-coil regions well protected in the absence of NDP52/liposomes?

These data are now in Figure 1---figure supplement 2B and Figure 2---figure supplement 2A-B. The coiled-coil region was not well protected in the absence of NDP52 or liposomes, and they showed moderate level of exchange rate. Thus these regions seem to have a moderate inherent stability, facilitating their ability to melt and bind membranes when activated.

[^1]: These authors contributed equally to this work.
